|
|
||||||||
-Chain Expression Is Independently Regulated in Primary and Secondary Lymphoid Organs


*
Unité dImmunogénétique Cellulaire and
Unité dHistopathologie, Institut Pasteur, Paris, France; and
Institute of Virology and Immunobiology, University of Würzburg, Würzburg, Germany
The IL-2R is composed of three chains: IL-2R
, IL-2Rß, and
IL-2R
. In mice, IL-2R
is critical and determines IL-2 binding to
the tripartite IL-2R complex. To extend our previous studies, which
demonstrated that IL-2 regulates IL-2R
expression in vitro, we have
analyzed expression in IL-2-deficient mice in vivo. As in control
animals, CD4-CD8- thymocytes and bone
marrow-derived B220+ pre-B cells were Il-2R
positive. In
contrast, activated lymph node and splenic CD4 T cells
(CD4+CD69+) were found to be IL-2R
negative,
whereas
20% of the same cell populations from the
MLR/lpr strain, which also accumulate large numbers of
CD4-activated T cells in the presence of intact IL-2, retained
expression. A similar pattern of IL-2R
expression was found among
splenic CD8 cells from IL-2-/- and IL-2+/-
animals. These findings demonstrate that in primary lymphoid organs,
IL-2 is not directly involved in IL-2R
expression. However, at the
level of mature lymphocytes, and more specifically CD4 T cells, IL-2
remains in vivo, as in vitro, the most critical cytokine controlling
both IL-2R
expression and sensitivity to
IL-2.
This article has been cited by other articles:
![]() |
T. Vowinkel, K. C. Wood, K. Y. Stokes, J. Russell, C. F. Krieglstein, and D. N. Granger Differential expression and regulation of murine CD40 in regional vascular beds Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H631 - H639. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Gesbert, J.-L. Moreau, and J. Theze IL-2 Responsiveness of CD4 and CD8 lymphocytes: further investigations with human IL-2R{beta} transgenic mice Int. Immunol., August 1, 2005; 17(8): 1093 - 1102. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Valenzuela, C. Schmidt, and M. Mescher The Roles of IL-12 in Providing a Third Signal for Clonal Expansion of Naive CD8 T Cells J. Immunol., December 15, 2002; 169(12): 6842 - 6849. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Chastagner, J. Reddy, and J. Theze Lymphoadenopathy in IL-2-Deficient Mice: Further Characterization and Overexpression of the Antiapoptotic Molecule Cellular FLIP J. Immunol., October 1, 2002; 169(7): 3644 - 3651. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Yeh, S. Spicuglia, S. Kumar, A. Sanchez-Sevilla, P. Ferrier, and J. Imbert Control of IL-2R{alpha} gene expression: structural changes within the proximal enhancer/core promoter during T-cell development Nucleic Acids Res., May 1, 2002; 30(9): 1944 - 1951. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Reddy, P. Chastagner, L. Fiette, X. Liu, and J. Theze IL-2-induced tumor necrosis factor (TNF)-{beta} expression: further analysis in the IL-2 knockout model, and comparison with TNF-{{alpha}}, lymphotoxin-{beta}, TNFR1 and TNFR2 modulation Int. Immunol., February 1, 2001; 13(2): 135 - 147. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |